Logotype for Gemfields Group Limited

Gemfields Group (GML) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Gemfields Group Limited

H2 2024 earnings summary

7 Jan, 2026

Executive summary

  • 2024 was marked by revenue dropping to $213 million, cash constraints, and impairments due to multiple challenges, prompting a proposed $30 million rights issue to address near-term working capital and ensure completion of the second processing plant at Montepuez Ruby Mine (PP2).

  • Major issues included oversupply of Zambian emeralds, undersupply of premium rubies, luxury market softness, civil unrest in Mozambique, new tariffs, and a now-reversed Zambian export duty.

  • Completion of MRM's PP2 in June 2025 is expected to triple ruby processing capacity and deliver new revenue streams in late H2 2025.

Financial highlights

  • Revenue fell to $213 million, with Kagem contributing $78.7 million, MRM $117.2 million, and Fabergé $13.4 million.

  • EBITDA dropped to $41 million, significantly lower than 2023 and four times less than 2022.

  • Free cash flow was negative $58 million, reflecting heavy investment.

  • Net debt at year-end was $80.5 million, with $101.3 million drawn debt and expectations to reach $100 million net debt in 2025.

  • Adjusted EPS was negative at (1.8) cents, compared to 1.5 cents in 2023.

Outlook and guidance

  • Cost-cutting and business simplification are expected to reduce costs by around 20% in 2025.

  • CapEx and development spend will be significantly lower in 2025, with $21 million due to Consulmet for PP2 and total CapEx projected at $50 million.

  • Revenue assumptions for 2025 are conservative for Kagem and based on a three-year average for MRM.

  • The rights issue is critical for working capital and PP2 completion, with benefits expected in the second half of 2025.

  • First revenues from PP2 anticipated in late H2 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more